Abbott and Neurocrine to develop promising endometriosis drug

Nature reviews. Drug discovery · 2010 · vol. 9(8) , pp. 585 · doi:10.1038/nrd3246 · PMID:20671753 · W4252496280
review OA: bronze CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-28 ⓘ

Abbott and Neurocrine announced a partnership to develop a promising drug candidate for the treatment of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Gonadotropin-Releasing Hormone Hydrocarbons, Fluorinated Pyrimidines Clinical Trials as Topic Cooperative Behavior Drug Design Drug Industry Drug Industry Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Hydrocarbons, Fluorinated Hydrocarbons, Fluorinated Pyrimidines Pyrimidines

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-06T06:14:42.462031+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:07.008521+00:00
License: CC0 · commercial use OK